(3.229.142.91)
Users online: 2677    [ij] [ij] [ij] 
Email id
 

Research Journal of Pharmaceutical Dosage Forms and Technology
Year : 2019, Volume : 11, Issue : 3
First page : ( 152) Last page : ( 158)
Print ISSN : 0975-234X. Online ISSN : 0975-4377.
Article DOI : 10.5958/0975-4377.2019.00026.0

Formulation and Evaluation of Oral Disintegrating Tablets of Montelukast Sodium and Desloratidine

Samineni Ramu*, Sumalatha K, Dharani G, Rachana J, Anitha P, Manasa K

Department of Pharmaceutics, Sree Vidyanikethan College of Pharmacy, Sree Sainath Nagar, A. Rangampet, Tirupati, AP-517102

*Corresponding Author E-mail: samineni.ramu@gmail.com

Online published on 31 December, 2019.

Abstract

The objective of the present study is to formulate and evaluate oral disintegrating tablets of Montelukast sodium and Desloratadine by direct compression using different concentrations of superdisintegrants like croscarmellose sodium, sodium starch glycolate and crospovidone. Montelukast sodium is a leukotriene receptor antagonist, used in the treatment of asthma and Desloratadine is a drug used to treat allergies the combination formulation is used for the treatment of allergic rhinitis. The Preparation contains 11 formulations by using direct compression method. The prepared batches of oral disintegrating tablets of Montelukast sodium and Desloratadine can be evaluated fort the pre compression parameters like angle of repose, Cars index, Hausner's ratio, tapped and bulk density. The post compression parameters were also studied including the Weight variation, Hardness, friability, Thickness, wetting time, In vitro disintegration and the water absorption ratio and In-vitro dissolution studies. In vitro dissolution studies showed that formulations F4, F10, F11 showed better dissolution of Desloratidine and Montelukast when compared with marketed formulation and among them F11 was found to be better formulation when compared to others. Based on the formulation development and results, F11 formulation was considered as the desired formulation which contains crospovidone 4% as a super disintegrant.

Top

Keywords

Active Pharmaceutical Ingredient (API), Oro Dispersible Tablets (ODT), Sodium Starch Glycolate (SSG), Micro Crystalline Cellulose (MCC), Disintegration Time (DT).

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
520,955,997 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.